Morning Briefing
Summaries of health policy coverage from major news organizations
Federal Advisory Panel. With Reservations, Recommends Keeping Avandia On The Market
Final decision on controversial diabetes drug now goes to FDA Commissioner Margaret Hamburg.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
